Verano Holdings (VRNO) Non-Current Assets (2021 - 2026)
Verano Holdings (VRNO) reported Non-Current Assets of $29.0 million for Q1 2026, down 0.65% year-over-year from $29.2 million in Q1 2025, and down 2.63% quarter-over-quarter from $29.8 million in Q4 2025.
Verano Holdings (VRNO) Non-Current Assets (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Non-Current Assets data on file, last reported at $29.0 million in Q1 2026.
- Non-Current Assets for Q1 2026 came in at $29.0 million, down 0.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $29.0 million (down 0.65% YoY), and the FY2025 annual result was $29.8 million, up 12.23% from the prior year.
- Non-Current Assets declined to $29.0 million in Q1 2026 per VRNO's latest filing, from $29.8 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $82.7 million in Q1 2023 and troughed at $21.7 million in Q3 2023.
- A 5-year average of $38.3 million and a median of $28.8 million in 2023 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2022 and 2024: Non-Current Assets plunged 68.12% in 2022, then gained 15.95% in 2024.
- A 5-year view of Non-Current Assets shows it stood at $72.1 million in 2022, then slumped by 60.37% to $28.6 million in 2023, then retreated by 7.05% to $26.6 million in 2024, then advanced by 12.23% to $29.8 million in 2025, then decreased by 2.63% to $29.0 million in 2026.
- Business Quant data shows VRNO's Non-Current Assets at $29.0 million in Q1 2026, $29.8 million in Q4 2025, and $28.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.22 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.40 Bn |
| 10 | Verano Holdings | - | - | 98.98 Mn | 29.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.02 Mn |
| Dec 31, 2025 | 29.80 Mn |
| Sep 30, 2025 | 28.22 Mn |
| Jun 30, 2025 | 28.98 Mn |
| Mar 31, 2025 | 29.21 Mn |
| Dec 31, 2024 | 26.56 Mn |
| Sep 30, 2024 | 25.13 Mn |
| Jun 30, 2024 | 26.27 Mn |
| Mar 31, 2024 | 26.73 Mn |
| Dec 31, 2023 | 28.57 Mn |
| Sep 30, 2023 | 21.67 Mn |
| Jun 30, 2023 | 81.82 Mn |
| Mar 31, 2023 | 82.67 Mn |
| Dec 31, 2022 | 72.08 Mn |
| Dec 31, 2021 | 226.11 Mn |